Lepu Medical Technology (Beijing) Co., Ltd. (CH: 300003), based in Beijing, China, is a leading interventional cardiology device company in China. Its product portfolio includes drug-eluting stents, occlusion devices, angioplasty-accessories and other cardiology-related devices and equipment. The company is a leader in the stent and occlusion product markets in China.
Warburg Pincus made an investment in the company in early 2007, and has helped the company develop its international business. The company completed an initial public offering on the Shenzhen Stock Exchange in October 2009.
Back to Previous Page